{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:59:26Z","timestamp":1791572366836,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd015084","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000}}],"reference-count":87,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015084.pub2","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:08:55Z","timestamp":1710835735000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prebiotics for induction and maintenance of remission in ulcerative colitis"],"prefix":"10.1002","volume":"2024","author":[{"given":"Vassiliki","family":"Sinopoulou","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Gordon","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Gregory","sequence":"additional","affiliation":[{"name":"Crohn's & Colitis UK; Hatfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Saadeh","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K","family":"Akobeng","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology; Sidra Medicine; Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD015084.pub2-BIB0001|cit1","first-page":"1061","article-title":"Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin","volume":"25","author":"Casellas","year":"2007","journal-title":"Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD015084.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(19)38637-8","article-title":"Microencapsulated sodium butyrate significantly modifies the microbiota in patients with inflammatory bowel disease mimicking prebiotic activity and proving effects on the treatment of the disease","volume":"156","author":"Facchin","year":"2019","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD015084.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e13914","DOI":"10.1111\/nmo.13914","article-title":"Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease","volume":"32","author":"Facchin","year":"2020","journal-title":"Neurogastroenterology & Motility"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD015084.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.1093\/ecco-jcc\/jjy222.779","article-title":"P665 Microencapsulated sodium butyrate significantly modifies the microbiota in patients with inflammatory bowel disease mimicking prebiotic activity and proving effects on the treatment of the disease","volume":"13","author":"Facchin","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"10.1002\/14651858.CD015084.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.nut.2008.11.017","article-title":"A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis","volume":"25","author":"Fujimori","year":"2009","journal-title":"Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD015084.pub2-BIB0006|cit6","first-page":"1","article-title":"Clinical effect of fibre supplement in patients with ulcerative colitis treated with 5-ASA","volume":"3","author":"Gravesen","year":"2016","journal-title":"Enliven: Journal of Dietetics Research and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD015084.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/S0261-5614(13)60108-9","article-title":"PP063-SUN Clinical effect of fibre supplement in patients with ulcerative colitis treated with 5-ASA","volume":"32","author":"Jensen","year":"2013","journal-title":"Clinical Nutrition"},{"issue":"7","key":"10.1002\/14651858.CD015084.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/00365529108998594","article-title":"Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission","volume":"26","author":"Hallert","year":"1991","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"14","key":"10.1002\/14651858.CD015084.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03326417","article-title":"Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial","volume":"37","author":"Kanauchi","year":"2002","journal-title":"Journal of Gastroenterology"},{"issue":"138","key":"10.1002\/14651858.CD015084.pub2-BIB0010|cit10","first-page":"S","article-title":"Prebiotic mixture of inulin plus oligofructose is effective adjunct therapy for treatment of mild to moderate ulcerative colitis","volume":"5","author":"Morse","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0011|cit11","unstructured":"Oligofructose-enriched inulin for the treatment of mild to moderate active ulcerative colitis https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT02093767"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/19490976.2018.1526583","article-title":"Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels","volume":"10","author":"Valcheva","year":"2019","journal-title":"Gut Microbes"},{"issue":"142","key":"10.1002\/14651858.CD015084.pub2-BIB0013|cit13","first-page":"S","article-title":"Beta-fructans reduce inflammation in mild to moderate ulcerative colitis through specific microbiota changes associated with improved butyrate formation and MUC2 expression","volume":"5","author":"Valcheva","year":"2012","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD015084.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00054725-201112002-00083","article-title":"Dietary beta-fructans reduce inflammation in patients with mild to moderate ulcerative colitis","volume":"17","author":"Valcheva","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0015|cit15","unstructured":"Ulcerative colitis relapse prevention by prebiotics https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02865707"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Valcheva R Armstrong H Kovic O Bording-Jorgensen M Veniamin S Perez-Munoz ME Double blind placebo-controlled trial for the prevention of ulcerative colitis relapses by \u03b2-fructan prebiotics: efficacy and metabolomic analysis medRxiv 2022","DOI":"10.1101\/2022.01.16.22269376"},{"issue":"6 Supplement","key":"10.1002\/14651858.CD015084.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/S0016-5085(21)01040-4","article-title":"Prebiotic beta-fructans prevent subclinical intestinal inflammation in ulcerative colitis patients who are in clinical remission","volume":"160","author":"Valcheva","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1016\/S1590-8658(00)80138-3","article-title":"Maintenance of remission of ulcerative colitis (UC): mesalamine, dietary fiber","volume":"32","author":"Copaci","year":"2000","journal-title":"Digestive and Liver Disease"},{"issue":"2","key":"10.1002\/14651858.CD015084.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1572-0241.1999.872_a.x","article-title":"Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis","volume":"94","author":"Fernandez-Banares","year":"1999","journal-title":"American Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD015084.pub2-BIB0020|cit20","first-page":"1","article-title":"Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study","volume":"7","author":"Hafer","year":"2007","journal-title":"BMC Gastroenterology"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0021|cit21","unstructured":"Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a prospective, randomised and controlled pilot study trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN92101486"},{"issue":"1","key":"10.1002\/14651858.CD015084.pub2-BIB0022|cit22","first-page":"1","article-title":"Randomized, double-blind, double-dummy trial of myrrh, chamomile, coffee charcoal compared to mesalazine in maintaining remission in ulcerative colitis","volume":"12","author":"Langhorst","year":"2012","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD015084.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S1873-9946(12)60301-8","article-title":"P281 Randomized, double-blind, double-dummy trial of myrrh, camomile and coffee charcoal compared to mesalazine in maintaining remission in ulcerative colitis","volume":"6","author":"Langhorst","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0024|cit24","unstructured":"Dietary fibre supplementation to prevent ulcerative colitis relapse: randomised double-blind placebo controlled clinical trial https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN75453816"},{"issue":"1","key":"10.1002\/14651858.CD015084.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"otaa005","DOI":"10.1093\/crocol\/otaa005","article-title":"Oat bran increased fecal butyrate and prevented gastrointestinal symptoms in patients with quiescent ulcerative colitis - randomized controlled trial","volume":"2","author":"Nyman","year":"2020","journal-title":"Crohn's & Colitis"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/nu13030938","article-title":"Impact of 2\u2032-fucosyllactose on gut microbiota composition in adults with chronic gastrointestinal conditions: batch culture fermentation model and pilot clinical trial findings","volume":"13","author":"Ryan","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1002\/14651858.CD015084.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1542-3565(04)00672-X","article-title":"An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial","volume":"3","author":"Seidner","year":"2005","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1-2","key":"10.1002\/14651858.CD015084.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/0142968X.1978.11904210","article-title":"Maintenance of remission in ulcerative colitis with sulphasalazine or a high-fibre diet: a clinical trial","volume":"3","author":"Davies","year":"1978","journal-title":"Journal of Plant Foods"},{"issue":"11","key":"10.1002\/14651858.CD015084.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/apt.17387","article-title":"Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study","volume":"57","author":"Ikegami","year":"2023","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD015084.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1093\/ecco-jcc\/jjac190.0043","article-title":"Unfermented beta-fructan fibres can induce gut inflammation and tumorigenesis in select inflammatory bowel disease patients mediated by gut microbiota","volume":"17","author":"Voisin","year":"2023","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0031|cit31","unstructured":"OptiMized rEsistaNt starch in inflammatory bowel Disease: The MEND Trial https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04520594"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0032|cit32","unstructured":"Resistant starch in pediatric inflammatory bowel disease (Crohn's disease or ulcerative colitis) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04522271"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0033|cit33","unstructured":"Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Signatures (PREDUCTOME) https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05579483"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0034|cit34","unstructured":"Personalized B-fructan diet in inflammatory bowel disease patients https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05615779"},{"issue":"1","key":"10.1002\/14651858.CD015084.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04523-8","article-title":"Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial","volume":"21","author":"Sadeghi","year":"2020","journal-title":"Trials"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jclinepi.2021.02.002","article-title":"No limitations to language, date, publication type, and publication status in search step of systematic reviews","volume":"133","author":"Aali","year":"2021","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD015084.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012731.pub2","article-title":"Prebiotics for the prevention of hyperbilirubinaemia in neonates","author":"Armanian","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD015084.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.18295\/squmj.2020.20.01.003","article-title":"Efficacy and safety of probiotics, prebiotics and synbiotics in the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"20","author":"Asha","year":"2020","journal-title":"Sultan Qaboos University Medical Journal"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0039|cit39","first-page":"623","article-title":"Inflammatory and microbiota-related regulation of the intestinal epithelial barrier","volume":"8","author":"Barbara","year":"2021","journal-title":"Frontiers in Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD015084.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nrgastro.2015.47","article-title":"Towards a more comprehensive concept for prebiotics","volume":"12","author":"Bindels","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.clnu.2019.11.002","article-title":"ESPEN practical guideline: clinical nutrition in inflammatory bowel disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clinical Nutrition"},{"issue":"17","key":"10.1002\/14651858.CD015084.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3748\/wjg.v17.i12.1519","article-title":"Potential beneficial effects of butyrate in intestinal and extraintestinal diseases","volume":"3","author":"Canani","year":"2011","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"nzy005","DOI":"10.1093\/cdn\/nzy005","article-title":"Health effects and sources of prebiotic dietary fiber","volume":"2","author":"Carlson","year":"2018","journal-title":"Current Developments in Nutrition"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0044|cit44","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiological Reviews"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods8030092","article-title":"Prebiotics: definition, types, sources, mechanisms, and clinical applications","volume":"8","author":"Davani-Davari","year":"2019","journal-title":"Foods"},{"issue":"12","key":"10.1002\/14651858.CD015084.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrgastro.2017.110","article-title":"The IBD interactome: an integrated view of aetiology, pathogenesis and therapy","volume":"14","author":"De Souza","year":"2017","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/10_2008_097","volume-title":"Food Biotechnology. Advances in Biochemical Engineering\/Biotechnology","volume":"111","author":"De Vrese","year":"2008"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0049|cit49","unstructured":"Deeks JJ Higgins JPT Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"7109","key":"10.1002\/14651858.CD015084.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD015084.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s12276-021-00617-8","article-title":"Slimy partners: The mucus barrier and gut microbiome in ulcerative colitis","volume":"53","author":"Fang","year":"2021","journal-title":"Experimental & Molecular Medicine"},{"issue":"11","key":"10.1002\/14651858.CD015084.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.mayocp.2014.07.002","article-title":"Ulcerative colitis: epidemiology, diagnosis, and management","volume":"89","author":"Feuerstein","year":"2014","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD015084.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD015084.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics","volume":"125","author":"Gibson","year":"1995","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.3748\/wjg.v27.i43.7572","article-title":"Minimum sample size estimates for trials in inflammatory bowel disease: A systematic review of a support resource","volume":"27","author":"Gordon","year":"2021","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0057|cit57","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0058|cit58","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0059|cit59","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0060|cit60","unstructured":"Higgins JPT Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007443.pub3","article-title":"Probiotics for maintenance of remission in ulcerative colitis","author":"Iheozor-Ejiofor","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD015084.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2050640620967899","article-title":"Sample-size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review","volume":"9","author":"Iheozor-Ejiofor","year":"2021","journal-title":"UEG Journal"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/01.NUR.0000270015.97457.9c","article-title":"Seeking control through the determination of diet: a qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease","volume":"21","author":"Jamieson","year":"2007","journal-title":"Clinical Nurse Specialist"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-020-00246-4","article-title":"Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies","volume":"17","author":"Kaur","year":"2020","journal-title":"Journal of Inflammation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD015084.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD015084.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3390\/nu13061780","article-title":"The microbiome as a therapy in pouchitis and ulcerative colitis","volume":"13","author":"LeBlanc","year":"2021","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0067|cit67","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"2","key":"10.1002\/14651858.CD015084.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012839.pub2","article-title":"Dietary interventions for induction and maintenance of remission in inflammatory bowel disease","author":"Limketkai","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD015084.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006634.pub3","article-title":"Probiotics for induction of remission in Crohn's disease","author":"Limketkai","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD015084.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tmaid.2018.09.007","article-title":"Are probiotics and prebiotics effective in the prevention of travellers\u2019 diarrhea: a systematic review and meta-analysis","volume":"27","author":"McFarland","year":"2019","journal-title":"Travel Medicine and Infectious Disease"},{"issue":"10114","key":"10.1002\/14651858.CD015084.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ctim.2019.01.010","article-title":"Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - what is the current evidence?","volume":"43","author":"Ooi","year":"2019","journal-title":"Complementary Therapies in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006474.pub3","article-title":"Prebiotics in infants for prevention of allergy","author":"Osborn","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD015084.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.gtc.2020.08.003","article-title":"Assessing severity of disease in patients with ulcerative colitis","volume":"49","author":"Pabla","year":"2020","journal-title":"Gastroenterology Clinics"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","volume":"16","author":"Raine","year":"2022","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0078|cit78","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"3","key":"10.1002\/14651858.CD015084.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"830S","DOI":"10.1093\/jn\/137.3.830S","article-title":"Prebiotics: the concept revisited","volume":"173","author":"Roberfroid","year":"2007","journal-title":"The Journal of Nutrition"},{"issue":"10","key":"10.1002\/14651858.CD015084.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","article-title":"Probiotics and prebiotics in intestinal health and disease: from biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0081|cit81","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"10","key":"10.1002\/14651858.CD015084.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005496.pub5","article-title":"Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants","author":"Sharif","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015084.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00430-016-0481-y","article-title":"Effects of prebiotics on immune system and cytokine expression","volume":"1","author":"Shokryazdan","year":"2017","journal-title":"Medical Microbiology and Immunology"},{"issue":"11","key":"10.1002\/14651858.CD015084.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD015084.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ibd\/izz265","article-title":"Cost burden of Crohn\u2019s disease and ulcerative colitis in the 10-year period before diagnosis - a Danish register-based study from 2003-2015","volume":"26","author":"Vadstrup","year":"2020","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015084.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ajcn\/nqy376","article-title":"Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"109","author":"Wilson","year":"2019","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD015084.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.sempedsurg.2017.10.003","article-title":"Clinical presentation of Crohn\u2019s, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes","volume":"26","author":"Yangyang","year":"2017","journal-title":"Seminars in Pediatric Surgery"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T17:17:35Z","timestamp":1765905455000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015084.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gut Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015084.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]}}}